Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation. Koudriavtseva T, Mainero C Front Hum Neurosci. 2016; 10:226. Epub 2016 May 13. PMID: 27242489. Abstract CommentRecommendBookmarkWatch
